Alere Gets FDA Clearance for Molecular Flu A/B Test | GenomeWeb

NEW YORK (GenomeWeb) — Alere said today that it has received US Food and Drug Administration Clearance for the Alere i Influenza A&B test.

According to Alere, the new assay is the only molecular test to detect and differentiate influenza A and B virus in less than 15 minutes. The test uses Alere's proprietary "Molecular. In Minutes" (MIM) isothermal nucleic acid amplification technology, which unlike PCR does not require thermal cycling or DNA purification, thus reducing time to result.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: weighting scheme increases GWAS power, and more.

Marc Tessier-Lavigne is to be the next president of Stanford University.

Walgreens has given Theranos 30 days to fix its lab issues, the Wall Street Journal reports.

Journals and research funding agencies pledge to enable the sharing of Zika virus research.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.